PODD

SELL

Insulet Corporation

Healthcare · Rank #158 · Analyzed Jul 13, 2026

$161.28

Current Price

$75.14

Intrinsic Value

-53.4%

Upside/Downside

3.5/10

Score

3.5/5

Quality

Analysis Summary

Valuation Consensus0/3 methods agree

Quality Score3.5/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 53.4%

Fair Value Range

Low$15.55

Base (IV)$75.14

High$104.07

Entry Points

Conservative$10.89

Moderate$15.55

Aggressive$52.60

Quality & Moat Breakdown

Return on Equity23.0% → 1.0/1.0

Debt LevelD/E 78 → 0/1.0

Revenue QualityGrowth 22.7%, margin Δ+21.5% +recovery → 1.0/1.0

Moat Strength3.0/5 → 0.5/1.0

Profit Margins10.4% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.